抗治疗性创伤后精神紧张症的MDMA疗法试验在澳大利亚纽卡斯尔开始。 MDMA therapy trial starts in Newcastle, Australia, for treatment-resistant PTSD.

在莫妮卡·施韦克勒博士牵头的临床试验中,在澳大利亚纽卡斯尔启动了针对抗治疗性创伤后精神紧张症的Monica Schweickle医生的MDMA辅助疗法。 MDMA-assisted therapy has launched in Newcastle, Australia, in a clinical trial led by Dr. Monica Schweickle targeting treatment-resistant PTSD. 这项研究涉及有控制、由医疗监督的会议,将MDMA与心理治疗相结合,以评估安全和有效性。 The study involves controlled, medically supervised sessions combining MDMA with psychotherapy to assess safety and effectiveness. 它是探讨将精神病作为心理健康治疗方法的全球研究的一部分,早期国际结果显示有希望。 It is part of global research exploring psychedelics as mental health treatments, with early international results showing promise. 审判在严格的监管监督下进行,目的是为对传统疗法没有反应的病人提供新的选择。 The trial operates under strict regulatory oversight, aiming to provide new options for patients unresponsive to traditional therapies.